Urigen N.A. Completes Shareholder Meeting
6/29/2007 12:57:16 PM
BURLINGAME, Calif.--(BUSINESS WIRE)--
Urigen N.A., Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders, has successfully completed its shareholder meeting with Urigen’s shareholders approving the merger with Valentis, Inc.
comments powered by